You are here

FB3 Achieves Finalist Status in Informa's Editor's Choice Awards

Unique product showcased at SupplySide West

NEW YORK, NY -- American Medical Holdings Inc.,New York ,NY, in association with Japan BioActives K.K. Tokyo, Japan, have announced that their innovative product, FB3® Fusion Ingredient, has been selected as one of five top finalists by Informa Exhibitions for its 2015 SupplySide CPG Editor’s Choice Awards.

"We have worked diligently since 2010 to compose and research the benefits of FB3® Fusion Ingredient," says Vladimir Badmaev, MD PhD, founder and President of American Medical Holdings Inc., author and product inventor. "The result is a fusion of three botanicals with synergistic mechanisms of action that enhance each other's utility in preventing excess dietary fat absorption for continued long-term efficacy."